menu
    • menu

    Company profile for Marinomed Biotech

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Marinomed Biotech AG is a biopharmaceutical company. It specializes in the development of innovative products based on patent protected technology platforms in the field of respiratory and ophthalmic diseases. Marinomed has received multiple prestigious research awards for its activities. Marinomed has developed two platforms to date: the Marinosolv® technology platform and the Carragelose® platform.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Marinomed BiotechAustria Flag
    Country
    Country
    Austria
    Address
    Address
    Veterinärplatz 1 1210 Vienna
    Telephone
    Telephone
    +43 1 25077 4460
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.marinomed.com/en
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Marinomed Biotech AG Reveals 1H 2025 Performance
    Marinomed Biotech AG Reveals 1H 2025 Performance

    17 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-17/marinomed-biotech-ag-announces-results-for-the-first-half-year-of-2025

    PHARMAWEB
    17 Sep 2025
    Share Share
    Marinomed Biotech Resolves Capital Increase Of 61,607 Shares
    Marinomed Biotech Resolves Capital Increase Of 61,607 Shares

    16 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-16/marinomed-biotech-ag-resolves-capital-increase-excluding-statutory-subscription-rights-by-issuing-61

    PHARMAWEB
    16 Sep 2025
    Share Share
    Marinomed Biotech AG Secures EUR 2.5M Convertible Bond Agreement
    Marinomed Biotech AG Secures EUR 2.5M Convertible Bond Agreement

    01 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-01/marinomed-biotech-ag-agreement-on-the-key-terms-of-the-issue-of-a-secured-eur-25mn-convertible-bon

    PHARMAWEB
    01 Sep 2025
    Share Share
    Extraordinary Meeting Approves Sale of Carragelose Division
    Extraordinary Meeting Approves Sale of Carragelose Division

    19 Dec 2024

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2024-12-19/marinomed-biotech-ag-extraordinary-general-meeting-approves-sale-of-carragelose-division

    PHARMAWEB
    19 Dec 2024
    Share Share
    Marinomed Biotech Excludes Subscription Rights for Capital Increase
    Marinomed Biotech Excludes Subscription Rights for Capital Increase

    27 Nov 2024

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2024-11-27/marinomed-biotech-ag-publication-of-a-report-on-the-exclusion-of-subscription-rights-for-a-possible

    PHARMAWEB
    27 Nov 2024
    Share Share
    Marinomed Biotech Sells Carragelose Business to Unither Pharma
    Marinomed Biotech Sells Carragelose Business to Unither Pharma

    27 Nov 2024

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2024-11-27/marinomed-biotech-ag-signs-agreement-for-sale-of-carragelose-business-to-french-unither-pharmaceutic

    PHARMAWEB
    27 Nov 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search